Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Injection of Liquid Phase Concentrated Growth Factor Versus Conventional Arthrocentesis in Management of Temporomandibular Disc Displacement: A Randomized Controlled Clinical Trial

NCT07075276 is registered in ClinicalTrials.gov with Horus University as lead sponsor.

NCT NCT07075276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07075276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Injection of Liquid Phase Concentrated Growth Factor Versus Conventional Arthrocentesis in Management of Temporomandibular Disc Displacement: A Randomized Controlled Clinical Trial
Lead sponsor
Horus University
Phase
Not applicable
Overall status
Recruiting
Start date
October 1, 2025
Completion date
December 1, 2026
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anterior disc displacement, internal derangement of the tempromandibular joint, temporomandibular disorders (tmd)